FSUE "Moscow Endocrine Plant” (ENDOPHARM) develops and produces high-quality medicines with proven efficacy and safety, ensuring their availability to citizens of the Russian Federation within the framework of the state import substitution strategy and FSUE "Moscow Endocrine Plant’s" program for the introduction of medicines. Priority is given to projects on the creation of children's medicinal forms of drugs used in the treatment of chronic pain syndrome and epilepsy.
One of the important aspects of ENDOPHARM's activities is post-registration monitoring of the use of released medicines in clinical practice and the implementation of research initiatives aimed at improving the availability and quality of treatment.
The scientific and practical seminar "Modern trends in the diagnosis and treatment of epilepsy in children", organized with the scientific support of the State Budgetary Healthcare Institution of Moscow "Scientific and Practical Center of Child Psychoneurology of the Department of Health of Moscow" (hereinafter - GBUZ "SPC CP DHM") became a platform for dialogue between ENDOPHARM employees and more than 300 practicing medical specialists, including neurologists, epileptologists, neurological surgeons, pediatricians, rehabilitation therapists and psychiatrists. During the event, participants shared their experience and the results of current research in diagnosis and treatment of epilepsy in children.
When discussing modern treatment protocols, the seminar participants considered the comparative effectiveness of various groups of seizure medications. Medical community representatives focused on the importance of the appearance in Russia of new children's forms of domestic medicines produced by ENDOPHARM, intended for the treatment of prolonged acute seizures in epilepsy in children and the advantages of their use in inpatient and outpatient settings compared with invasive dosage forms.
The release of medicines used in the treatment of socially significant diseases is an important function of the FSUE “Moscow Endocrine Plant“ in the context of the state policy to ensure drug safety of the country. The program for the introduction of ENDOPHARM medicines is being developed in cooperation with representatives of the scientific and medical communities in order to meet the modern demands of the domestic healthcare system.
FSUE "Moscow Endocrine Plant" Supports Educational Projects in Epilepsy Treatment
24 May 2021
Comment type is not specified in the component properties.